Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 680 of 1,261
  1. US 9409956

    Salmonella typhi Ty21a expressing Yersinia pestis F1-V fusion protein and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  2. US 9410154

    HBV treatment

    Benitec Biopharma Limited · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  3. US 9410198

    Compostions and methods of nucleic acid-targeting nucleic acids

    Caribou Biosciences, Inc. · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  4. US 9410913

    Methods and systems for measuring and using the oxidation-reduction potential of a biological sample

    Aytu BioScience, Inc. · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  5. US 9410969

    Method for determining and treating amyotrophic lateral sclerosis

    China Medical University · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  6. US 9409992

    Mesothelin domain-specific monoclonal antibodies and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  7. US 9409990

    Methods of inhibiting tumor growth by antagonizing IL-6 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  8. US 9409963

    Fibromodulin peptide

    The Regents of the University of California · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  9. US 9409934

    Cyclohexenyl nucleic acids analogs

    Ionis Pharmaceuticals, Inc. · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  10. US 9409944

    Compositions and methods for inhibiting proteases

    The Regents of the University of California · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  11. US 9409905

    Antibacterial compounds and methods for use

    PTC THERAPEUTICS, INC. · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  12. US 9409884

    5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them

    Rigel Pharmaceuticals, Inc. · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  13. US 9409880

    Modulators of TLR3/dsRNA complex and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  14. US 9408901

    Compositions, methods and uses for dengue virus serotype-4 constructs

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  15. US 9408839

    Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype

    VANDA PHARMACEUTICALS INC. · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  16. US 9408896

    Vaccination of companion animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  17. US 9408820

    Broncholytic drug on the basis of prostaglandin

    OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOST'YU “NOXI LAB” · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  18. US 9408844

    Methods for treating inflammatory conditions

    Melior Discovery, Inc. · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  19. US 9408813

    Small-molecule inhibitors of dengue virus proteases

    The Board of Regents of the University of Texas System · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  20. US 9402840

    Crystalline form of a quinolinone-carboxamide compound

    Theravance Biopharma R&D IP, LLC · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  21. US 9404113

    Antisense modulation of PTP1B expression

    Ionis Pharmaceuticals, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  22. US 9404088

    Chitosan-based non-viral methods for transfecting gut cells in vivo

    ENGENE, INC. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  23. US 9402830

    Methods of treating dyskinesia and related disorders

    Melior Discovery, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  24. US 9404081

    Pyruvate kinase activators for use in therapy

    Agios Pharmaceuticals, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.